CAR-T Evolution: Next-Generation Cell Therapy Competitive Intelligence and Allogeneic Market Disruption; Strategic Analysis of Solid Tumor Expansion, Manufacturing Innovation, and Value-Based Contracting Models
The global CAR-T cell therapy market is at a critical inflection point, with forecasts ranging from a conservative $15.97 billion to a transformative $217.6 billion by the early 2030s, contingent almost entirely on breakthrough success in solid tumors. This comprehensive report, CAR-T Evolution: Nex ...
